Literature DB >> 22359158

Moringa coagulant as a stabilizer for amorphous solids: Part I.

Santosh Bhende1, Namdeo Jadhav.   

Abstract

Stabilization of amorphous state is a focal area for formulators to reap benefits related with solubility and consequently bioavailability of poorly soluble drugs. In the present work, an attempt has been made to explore the potential of moringa coagulant as an amorphous state stabilizer by investigating its role in stabilization of spray-dried (amorphous) ibuprofen, meloxicam and felodipine. Thermal studies like glass forming ability, glass transition temperature, hot stage microscopy and DSC were carried out for understanding thermodynamic stabilization of drugs. PXRD and dissolution studies were performed to support contribution of moringa coagulant. Studies showed that hydrogen bonding and electrostatic interactions between drug and moringa coagulant are responsible for amorphous state stabilization as explored by ATR-FTIR and molecular docking. Especially, H-bonding was found to be predominant mechanism for drug stabilization. Therein, arginine (basic amino acid in coagulant) exhibited various interactions and played important role in stabilization of aforesaid amorphous drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359158      PMCID: PMC3364398          DOI: 10.1208/s12249-012-9755-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

1.  Arginine-assisted solubilization system for drug substances: solubility experiment and simulation.

Authors:  Atsushi Hirano; Tomoshi Kameda; Tsutomu Arakawa; Kentaro Shiraki
Journal:  J Phys Chem B       Date:  2010-10-28       Impact factor: 2.991

2.  Role of hydrogen bonding interactions in directing one-dimensional thiol-assisted growth of silver-based nanofibers.

Authors:  Emil Avier Hernandez; Bertina Posada; Roberto Irizarry; Miguel E Castro
Journal:  J Phys Chem B       Date:  2005-04-21       Impact factor: 2.991

3.  Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier.

Authors:  Aljaz Godec; Uros Maver; Marjan Bele; Odon Planinsek; Stane Srcic; Miran Gaberscek; Janko Jamnik
Journal:  Int J Pharm       Date:  2007-05-18       Impact factor: 5.875

4.  Isolation and characterization of a flocculating protein from Moringa oleifera Lam.

Authors:  U Gassenschmidt; K D Jany; B Tauscher; H Niebergall
Journal:  Biochim Biophys Acta       Date:  1995-04-13

5.  Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.

Authors:  Evangelos Karavas; Georgios Ktistis; Aristotelis Xenakis; Emmanouel Georgarakis
Journal:  Eur J Pharm Biopharm       Date:  2006-05-03       Impact factor: 5.571

6.  Stability study of amorphous valdecoxib.

Authors:  Anshuman A Ambike; K R Mahadik; Anant Paradkar
Journal:  Int J Pharm       Date:  2004-09-10       Impact factor: 5.875

7.  Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

8.  Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.

Authors:  Hoda A El-Maradny; Sana A Mortada; Ola A Kamel; Ahmed H Hikal
Journal:  Acta Pharm       Date:  2008-12       Impact factor: 2.230

9.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

10.  Solubility enhancement of gluten and organic compounds by arginine.

Authors:  Tsutomu Arakawa; Yoshiko Kita; A Hajime Koyama
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

View more
  1 in total

1.  Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.

Authors:  Suhail B Noolkar; Namdeo R Jadhav; Santosh A Bhende; Suresh G Killedar
Journal:  AAPS PharmSciTech       Date:  2013-03-13       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.